this appeal involves a complex dispute over the ownership of a patent.israel project ibep appeals from a judgment in a patent infringement action granting yeda research and development company,yeda motion for summary judgment on the ground that ibep lacked standing to bring the suit because it did not have sole ownership of the patent.this court affirms.
factual background 
four contracts 
this dispute over ownership of the patent involves four contracts.yeda is an israeli corporation that markets and commercializes inventions resulting from research conducted at the weizmann institute of science,a research institute.yeda entered into negotiations with,a joint venture formed in israel in between yeda and,an israeli company wholly owned by serono international,to finance various weizmann research projects and to commercialize the results of the research.on september,yeda and executed a handwritten agreement,which provided that would finance four specified research projects during a five year project term,including the one at issue here.this initial agreement was later amended,as will be explained later.that same day,yeda sent a side letter to offering to cooperate with in revising the contract if it found outside funding.
shortly afterwards in,began negotiating with ibep,a new york limited partnership,to secure funding for the four research projects.these negotiations generated three agreements.first,on december,ibep entered into a contract with the state of israel the r d contract whereby ibep committed to spend between million and million on four research programs.paragraph of the r d contract provides ibep will be entitled,subject to two paragraphs which are not applicable,to exploit all the research results,including any patents,in any manner,including the manufacture of products,granting of licenses,transfer sale of any rights in any matter resulting from the research.the israeli government consented to the terms of the two contracts which ibep and were about to enter.three days later,ibep signed a pair of contracts with on december.all three contracts were set to expire on december,and were to be construed in accordance with the laws of the state of israel 
the first contract between ibep and,called the and development contract d contract,provided that ibep would fund the research operations conducted by in cooperation with yeda.of particular significance to this dispute,paragraph ix a of this contract specified 
on behalf of the partnership ibep,developer shall apply for and obtain patents in developer yeda name s on all inventions resulting from the r d programs which developer,in its sole discretion,considers advisable to apply for and obtain provided,however,that the beneficial ownership of all rights,title and interest in and to such patents and patent applications that form a part of the proprietary information shall be and hereby are assigned to the partnership from the date the partnership shall have made the first payment to the developer pursuant to this agreement in perpetuity,unless and until the developer shall have purchased the proprietary information in respect thereof according to the provisions of the tos agreement.
emphasis added.paragraph x a,entitled property rights,then provides 
subject to the provisions of the tos agreement,any and all of the proprietary information shall become the sole property of the partnership ibep.subject to the provisions of paragraph ix above regarding the registration of patents in developer yeda name s,developer shall assign to ibep all its rights,title and interest in and to the proprietary information and shall require all persons employed by it,presently or in the future,to do the same unless and until developer shall become the owner of all of the partnership rights,title and interest in and to the proprietary information in accordance with the tos agreement.nothing contained herein shall prevent developer from including in any patent registration the name s of the individual inventor s as required by law,provided that no proprietary rights are vested in such individuals.
for purposes of this contractual provision,the term proprietary information was defined,in relevant part,to mean 
any and all inventions,patent applications and patents wherever applied for or granted,trade secrets,technical information including all blueprints,plans,workbooks,drawings,specifications,formulas and processes and other technology or knowhow developed in the r d programs.
emphasis added.the r d programs referenced by this agreement were designed to be effective for a period with the execution period defined in the r d agreement with israel,that is until december.
the other contract between ibep and is the technology option and sale agreement the tos contract,which was executed on december.in the paragraph entitled property rights,the contract repeats,any and all of the proprietary information developed during the term of the d agreement shall become the sole property of the partnership ibep subject to the right of to exercise the option with respect thereto,as provided in paragraph hereof.emphasis added.in paragraph,entitled options to purchase proprietary information,the tos contract granted interyeda the sole and exclusive option to purchase all of ibep rights,title and interest in and to the proprietary information relating to each product that has been reduced to practice or in respect to which a patent application has been filed prior to the expiration or termination of the d agreement december.if timely exercised the option,it had to make certain payments to ibep.never exercised that option.
moreover,the tos agreement expressly discusses research and development after the term of the d contract.it gives ibep the right to finance additional research and development if,after the term of the d agreement and during the term of the tos contract,desires to conduct further research and development with respect to the proprietary information.it then provides if after the termination of the d agreement and during the term hereof,any product is reduced to practice or if a patent application is filed with respect thereto,ibep shall be entitled to payments ibep right to royalties would be proportionately reduced if more money is spent to conduct additional research and development than has been spent by ibep.
finally,one day after ibep and signed these contracts,and yeda amended their original agreements.this amended agreement distinguishes between unrelated results,results,new results,and any other results.it provides the title in and to any new result which will be discovered or developed during the project term other than an unrelated result shall belong to ibep immediately upon its discovery or development.the parties agreed that title to any results stemming from yeda research between september,and december,would still vest in yeda.moreover,it provides that title to any other results which shall not belong to ibep would belong to yeda.the project term of the contract was defined to be the period of the contract effective september.
the inventions 
by april the expiration of the original contract,but prior to the termination of the scientists,who worked in the r d program directed at identifying novel factors,discovered and partially purified the tumor necrosis factor binding protein tbp in human urine.this protein,when bound to a substance in the body called the tumor necrosis factor tnf,proved capable of combating rheumatoid arthritis.tbp is the subject matter of patent the patent entitled tumor necrosis factor inhibitory protein and its purification,which issued on november,naming four inventors david wallach,hartmut engelmann,daniel aderka,and menachem rubinstein.yeda was named the assignee of the patent.the patent contains three separate claims.patent.claim recites a protein capable of inhibiting the binding of tnf to cells and of inhibiting the cytotoxic effect of tnf,wherein said protein is obtainable from human urine and has certain features.id.the parties do not dispute that this subject matter was discovered prior to the expiration of the d agreement on september,yeda filed the israeli patent application,the priority document,relating to these discoveries.
claims and of the patent,however,relate to inventions made in,after the termination of ibep d contract with.claim covers a substantially purified protein obtainable from human urine,capable of interacting with tnf so as to inhibit the binding of tnf to cells and to inhibit the cytotoxic effect of tnf and containing a specifically identified amino acid sequence.id.claim recites a pharmaceutical composition for use in treating conditions where tnf is to be eliminated from the body or its effect in the body is to be antagonized,comprising a protein in accordance with claim and a pharmaceutically acceptable carrier.id.
one of the named inventors,menachem rubinstein began working with the other inventors on this project in january,after the expiration of the d contract.both parties agree that rubinstein was brought into the research team at this time to help purify and sequence the protein listed in claims and of the patent.he worked with engelmann in to complete the purification,in rubinstein words,and they purified it sufficiently to determine an amino acid sequence.the inventors were able to isolate and purify this protein and ascertain the amino acid sequence of this protein sometime during.rubinstein and the other inventors executed an agreement dated july,assigning their rights in the invention to yeda the patent application was not filed until september,it claimed priority based on the priority document filed in september.
it is undisputed that professor rubinstein special skills,in collaboration with engelmann,resulted in the substantially purified tbp discussed in claims and of the patent and in the patent application.purification of the protein was needed to allow the scientists to determine the amino acid sequence.ibep claims that one of the named inventors,david wallach,partially purified the protein in,although the record seems to support at best a finding that wallach studies were focused on purifying the protein and he was attempting to do so.indeed,the record demonstrates that in,experiments to purify and characterize tbp were ongoing.nevertheless,ibep downplays rubinstein contribution as a continuation of wallach partial purification.
litigation 
in,ibep filed an action in the united states district court for the central district of california,alleging that the defendant pharmaceutical companies amgen,immunex corporation,wyeth,and wyeth pharmaceuticals,collectively amgen infringed claim of the patent with the pharmaceutical enbrel,a genetically engineered protein used to treat severe rheumatoid arthritis and psoriasis.shortly after the filing of the suit,yeda and serono moved to intervene only yeda prevailed.in,yeda filed a motion for summary judgment against ibep,arguing that ibep could not claim full title to the patent because the inventors were not rightly considered employees at the time of the agreement and thus did not pass the invention by operation of israeli law to,which was contractually required to assign title to ibep.agreeing with this argument,the district court granted the motion for summary judgment.ibep appealed we reversed,holding there were genuine issues of material fact on the issue of whether the inventors were employees at the time of the invention under israel law.of significance to this appeal,this court held 
on remand,if ibep is able to establish that wallach was an employee of at the time of the invention,ibep may be able to establish that it has an ownership interest in the patent.ibep can establish an ownership interest in the patent as long as the rights of even one of the inventors has passed to it.even an ownership interest,however,would not be sufficient to give ibep prudential standing to sue for infringement,as ibep would have to join all the other in order to establish such standing.
israel g project amgen,citations omitted.we noted the district court did not reach the question of standing.id.at.
after the case was remanded to the district court,yeda again moved for summary judgment,this time not surprisingly with a focus on standing.yeda argued that ibep lacked standing because the d contract expired in and because claims and of the patent were based on discoveries outside of the project term.as such,total ownership of the entire patent could not have been passed to ibep under the d contract.at most,yeda contended,ibep could claim only a pro rata undivided share of the entire patent,and without full ownership of the patent,ibep lacked standing to sue.
in a opinion,the district court allowed the defendant motion for summary judgment,holding that ibep lacked standing because claims and of the patent did not fall within the operation of the d agreement,and even if ibep had an ownership interest in tbp,the subject matter in claim,ibep at most had a partial interest in the whole patent.israel g project amgen,no.cv rgk manx.stymied again,ibep filed a timely notice of appeal.this court has appellate jurisdiction under.
discussion 
standard of review 
whether a party has standing to sue is a question of law that this court reviews de novo.prima tek ii.if appellant did not have standing to maintain an infringement action,then jurisdiction is not proper on appeal.see id.
although there are multiple ways to dispose of challenges to standing in the district court,the parties here addressed standing through a motion for summary judgment,one frequently used method.see generally charles alan wright,arthur miller edward cooper,federal practice and procedure ed pointing out that m any cases have suggested that summary judgment procedure is appropriate,but arguing it is better to use the preliminary hearing device as a means of requiring the plaintiff to carry the burden of establishing standing.this court reviews a district court grant of summary judgment de novo.conroy reebok int l.summary judgment is appropriate when there is no genuine issue as to any material fact and the moving party is entitled to judgment as a matter of law.c johnston ivac.in deciding whether summary judgment was appropriate,we view the evidence in a light most favorable to the party opposing the motion and with doubts resolved in favor of the opponent,which in this case is ibep.see transmatic,gulton.
the key question on appeal is whether ibep had standing to maintain the patent infringement action against amgen without the joinder of yeda,the assignee of the patent.ibep argues that it has standing because it is the sole exclusive owner of the patent by virtue of the d agreement.
it is a bedrock tenet of patent law that an invention presumptively belongs to its creator.teets chromalloy gas turbine.consistent with the presumption that the inventor owns his invention,the p atent issuance creates a presumption that the named inventors are the true and only inventors.ethicon,surgical.when,as here,multiple inventors are listed on the face of the patent,each presumptively owns a pro rata undivided interest in the entire patent,no matter what their respective contributions.id.this holding that a joint inventor as to even one claim enjoys a presumption of ownership in the entire patent flows from the language of,which permits joint inventors to apply for a patent jointly even though they did not physically work together or at the same time,each did not make the same type or amount of contribution,or each did not make a contribution to the subject matter of every claim of the patent.
still,issues of patent ownership are distinct from questions of inventorship.see beech aircraft edo,it is elementary that inventorship and ownership are separate issues.see also jones hardy,each claim must be considered as defining a separate invention.we have held all that is required of a joint inventor is that he or she contribute in some significant manner to the conception or reduction to practice of the invention,make a contribution to the claimed invention that is not insignificant in quality,when that contribution is measured against the dimension of the full invention,and do more than merely explain to the real inventors concepts the current state of the art.pannu iolab,citations om